Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 44.47
-1.79 (-3.87%)
At close: May 12, 2026
Acrobiosystems Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 171.25 | 165.57 | 123.83 | 153.59 | 203.73 | 174.21 |
Depreciation & Amortization | 65.85 | 65.85 | 53.25 | 42.02 | 34.5 | 13.94 |
Other Amortization | 22.28 | 22.28 | 19.02 | 17.45 | 9.6 | 3.99 |
Loss (Gain) From Sale of Assets | -0.07 | -0.07 | 0.35 | - | -0.21 | -0.28 |
Asset Writedown & Restructuring Costs | 4.11 | 4.11 | 0 | 37.76 | 24.22 | 5.7 |
Loss (Gain) From Sale of Investments | -10.57 | -10.57 | 1.48 | -5.37 | -21.63 | -8.1 |
Provision & Write-off of Bad Debts | -0.03 | -0.03 | 0.03 | 1.71 | 1.03 | - |
Other Operating Activities | 37.83 | 37.03 | 36.09 | -9.34 | -4.43 | 0.4 |
Change in Accounts Receivable | 74.15 | 74.15 | -41.23 | -56.05 | -17.64 | -26.27 |
Change in Inventory | -131.03 | -131.03 | -83.21 | -81.32 | -52.91 | -34.44 |
Change in Accounts Payable | 135.69 | 135.69 | -6.14 | 29.81 | 37.22 | 17.4 |
Change in Other Net Operating Assets | 11.6 | 11.6 | -6.37 | -5.93 | 7.25 | 1.18 |
Operating Cash Flow | 362.22 | 355.74 | 84.71 | 111.2 | 202.19 | 138.01 |
Operating Cash Flow Growth | 320.75% | 319.97% | -23.82% | -45.00% | 46.51% | 43.02% |
Capital Expenditures | -221.4 | -205.08 | -167.26 | -128.69 | -284.29 | -61.7 |
Sale of Property, Plant & Equipment | 1.21 | 1.21 | 4.71 | 0 | 0.35 | - |
Cash Acquisitions | - | - | -1.7 | 31.92 | - | - |
Investment in Securities | -66.74 | -220.98 | 276.98 | 0.19 | -913.61 | -722.05 |
Other Investing Activities | 174.17 | 104.71 | 0.12 | 5.26 | 21.11 | 8.05 |
Investing Cash Flow | -112.76 | -320.14 | 112.85 | -91.32 | -1,176 | -775.7 |
Short-Term Debt Issued | - | - | - | 6 | - | - |
Long-Term Debt Issued | - | 55.28 | 97.46 | - | - | - |
Total Debt Issued | 55.28 | 55.28 | 97.46 | 6 | - | - |
Long-Term Debt Repaid | - | -110.85 | -42.78 | -31.93 | -17.61 | -9.54 |
Net Debt Issued (Repaid) | -19.47 | -55.57 | 54.68 | -25.93 | -17.61 | -9.54 |
Issuance of Common Stock | - | - | 7.06 | - | 13.5 | 2,118 |
Repurchase of Common Stock | -23.85 | -23.85 | -12 | -10 | - | - |
Common Dividends Paid | -47.99 | -85.55 | -108.21 | -120 | -120 | - |
Other Financing Activities | -18 | -14.44 | - | - | - | -18.21 |
Financing Cash Flow | -109.31 | -179.42 | -58.48 | -155.93 | -124.11 | 2,090 |
Foreign Exchange Rate Adjustments | -6.57 | -7.76 | 7.65 | 13.85 | 6.42 | -2.26 |
Net Cash Flow | 133.57 | -151.59 | 146.73 | -122.2 | -1,092 | 1,450 |
Free Cash Flow | 140.82 | 150.66 | -82.56 | -17.49 | -82.1 | 76.31 |
Free Cash Flow Growth | - | - | - | - | - | -6.39% |
Free Cash Flow Margin | 15.87% | 17.98% | -12.80% | -3.22% | -17.30% | 19.82% |
Free Cash Flow Per Share | 0.85 | 0.90 | -0.49 | -0.10 | -0.49 | 0.57 |
Cash Income Tax Paid | 84.09 | 53.97 | 60.55 | 48.67 | 36.43 | 41.4 |
Levered Free Cash Flow | -119.88 | -118.22 | -156.74 | -25.36 | -173.01 | 41.41 |
Unlevered Free Cash Flow | -119.26 | -116.54 | -154.52 | -23.67 | -171.17 | 42.13 |
Change in Working Capital | 71.55 | 71.55 | -149.35 | -126.63 | -44.62 | -51.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.